Guy’s and St Thomas’ NHS Foundation Trust is one of the largest NHS trusts in the UK, with a turnover of £1.3 billion, contracts with 130 clinical commissioning bodies, and over 2 million patient contacts each year – over a million in hospital services and 859,000 in the community.
The tust provides first-class general and specialist services from two major hospital sites that serve the local populations of Southwark and Lambeth. It is also a national referral centre for highly rated, specialist services, and is home to the Evelina London Children’s Hospital. The Trust provides a full range of community services to Lambeth and Southwark.
As part of King’s Health Partners Academic Health Sciences Centre (AHSC), Guy's and St Thomas' NHS Foundation Trust is a pioneer in health research, and provides high quality teaching and education. This partnership with King’s College London, and King’s College Hospital and South London and Maudsley NHS Foundation Trusts helps provide the latest treatments for patients alongside the best possible care.
Guy’s and St Thomas’ NHS Foundation Trust specialises in cancer, cardiovascular, dental, dermatology, imaging, children’s, renal, and women’s health services. It also provides one of the largest critical care services in London.
Guy’s and St Thomas’ NHS Foundation Trust is home to the largest dental school in Europe.
Guy’s and St Thomas’ NHS Foundation Trust performs a third of all UK children’s kidney transplants, has the largest living donation kidney programme, and has the most successful pancreas transplant programme in the UK.
Guy’s and St Thomas’ NHS Foundation Trust has excellent clinical research facilities including a Good Manufacturing Practice Facility for the production of novel cellular therapies for first in man (phase 1) clinical trials, as well as one of the largest imaging and biomedical engineering research groups in Europe.
A new £160 million Cancer Centre at Guy’s will open in autumn 2016; this will combine first-class clinical care with groundbreaking research.
Guy's and St Thomas' NHS Foundation Trust is committed to pioneering clinical research; at any one time more than 1,375 leading edge research projects are on-going across the Trust’s hospital sites, including over 345 clinical trials of medicinal products.
In 2011, the Guy’s and St Thomas’ Biomedical Research Centre was awarded £59 million of funding over five years by the National Institute for Health Research. In 2014/15, BRC researchers contributed to over 390 research papers.
With their academic partner, King’s College London, Guy’s and St Thomas’ hosts five Medical Research Council (MRC) centres, almost a quarter of the UK total, focusing on: transplant; asthma; developmental neurobiology; environment and health; and social, genetic and development psychiatry.
As part of King’s Health Partners, the Trust works with its local NHS and academic partners to translate cutting-edge research into excellent patient care through world-class education and training.
In 2012, the Trust’s Clinical Research Facility was awarded £5.6 million from the National Institute for Health Research to continue to expand its groundbreaking clinical research.
- Guy’s and St Thomas’ NHS Foundation Trust's Standardised Mortality Rate is 76, well below the national average of 100
- 97% (national average 95%) of inpatients and 84% (national average 87%) of A&E patients would recommend the Trust to family and friends
- 90% (national average 89%) of cancer patients rate their care at Guy’s and St Thomas’ as excellent or very good
- In 2014, Guy’s and St Thomas’ NHS Foundation Trust remained among the best in London in the national inpatient survey
- In the latest Staff Friends and Family Test, 91% of our staff would recommend the Trust as a place to be treated (national average 79%) and 77% of staff would recommend the Trust as a place to work (national average was 63%)
- See Our Quality Story on the Trust website www.guysandstthomas.nhs.uk/ourqualitystory for further details about our performance.
Chief Executive: Amanda Pritchard